Biophytis launches OBA phase 2 clinical study in obesity with BIO101 (20-hydroxyecdysone)
Promising preclinical results obtained in obesity support the OBA Phase 2 clinical study expected to start mid-2024PARIS, FRANCE AND CAMBRIDGE,...
Year: 2024
Medicure Reports Financial Results for Quarter and Year Ended December 31, 2023
WINNIPEG, MB / ACCESSWIRE / April 8, 2024 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTCPINK:MCUJF), a company focused on...
Board-Certified and Highly Accomplished, Active Duty Military Ophthalmologist Now Treating Patients at LasikPlus Louisville
LOUISVILLE, KY / ACCESSWIRE / April 8, 2024 / Kentucky-based ophthalmologist and LASIK eye surgeon Dr. Gregory Bryant Giles is...
Cantargia presents unique effects of nadunolimab in pancreatic cancer
LUND, SE / ACCESSWIRE / April 8, 2024 / Cantargia (STO:CANTA) Cantargia (Cantargia AB; Nasdaq Stockholm: CANTA) today presented new...
Nava Health to Open Sixth Center in the Baltimore-Washington Metropolitan Area
New Hunt Valley, Maryland Center Expands the Company's Footprint to Meet Growing Demand for Integrative CareCOLUMBIA, MD / ACCESSWIRE /...
The Assistance Fund Ranks #11 in The NonProfit Times’ ‘2024 Best Nonprofits to Work For’
The NonProfit Times Names The Assistance Fund Among Best Nonprofits To Work ForORLANDO, FL / ACCESSWIRE / April 8, 2024...
Model N to be Acquired by Vista Equity Partners For $1.25 Billion
Model N Stockholders to Receive $30.00 Per Share in CashSAN MATEO, Calif.--(BUSINESS WIRE)--Model N (NYSE: MODN), a leader in revenue...
Sona Nanotech Secures Grant Funding to Support Intellectual Property Strategy and Development
Halifax, Nova Scotia--(Newsfile Corp. - April 8, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company" or "Sona")...
American College of Osteopathic Family Physicians Honors 2024 Outstanding Members of the Profession
Each year, ACOFP honors in-practice physicians, residents and students who make exemplary contributions to the field of osteopathic medicine.CHICAGO, IL...
Andor Health Earns Highest Client Experience Ranking in Black Book Hospital Survey for Virtual Care Collaboration Solutions
TAMPA, FL / ACCESSWIRE / April 8, 2024 / Black Book Research unveils leading innovators in virtual health solutions utilizing...
Cloud DX Announces Proposed $2.8 Million Private Placement
KITCHENER, ON / ACCESSWIRE / April 8, 2024 / Cloud DX Inc. ("Cloud DX" or the "Company") (TSXV:CDX)(OTC:CDXFF) is pleased...
Jaguar Health Granted Extension Until August 13, 2024, to Regain Compliance with Nasdaq’s Bid Price Requirement
Top line results forthcoming for company's phase 3 OnTarget trial of crofelemer for preventative treatment of cancer therapy-related diarrheaSAN FRANCISCO,...
Avant Brands Launches $3.88 Million Non-Brokered Private Placement Offering
KELOWNA, BC / ACCESSWIRE / April 8, 2024 / Avant Brands Inc. (TSX:AVNT)(OTCQX:AVTBF)(FRA:1BU0) ("Avant" or the "Company"), a leading producer...
DEA Faces Marijuana Legal Scrutiny: Hindering MMJ BioPharma Cultivation Marijuana Supply For Clinical Trials
Exposing the Secret: Federal Marijuana Production Remains NonexistentThe DEA Games Continue To Delay Legitimate Marijuana Clinical Trials and ResearchWASHINGTON, DC...
1933 Industries Announces Purchase of 9% Interest of Cultivation and Production Subsidiary
VANCOUVER, BC / ACCESSWIRE / April 8, 2024 / 1933 Industries Inc. (the "Company" or "1933 Industries") (CSE:TGIF)(OTCQB:TGIFF), a Nevada-focused...
Bristol Myers Squibb Releases 2023 ESG Report Demonstrating Progress and Setting New Long-Term Goals
Company builds on its strengths to advance patient access, product innovation, culture and inclusion and diversityNORTHAMPTON, MA / ACCESSWIRE /...
Clearday to Host a Solar Watch Event– the Event of the Decade occurs today. A total Solar Eclipse is ready to travel from Texas to Maine.
San Antonio, TX, April 08, 2024 (GLOBE NEWSWIRE) -- Clearday (OTCQX CLRD) is pleased to announce that Clearday Club Leon...
GRI Bio Announces Abstract Accepted for Poster Presentation at the 2024 American Thoracic Society International Conference
LA JOLLA, CA, April 08, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a...
Longeveron Issues Letter to Shareholders Highlighting Corporate Strategy, Clinical Pipeline and 2024 Key Priorities and Goals
MIAMI, April 08, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing regenerative medicines, today...
CorMedix Inc. Announces Commercial Agreement With ARC Dialysis, LLC
BERKELEY HEIGHTS, N.J., April 08, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing therapeutic...